Medicine Technology 🌱 Environment Space Energy Physics Engineering Social Science Earth Science Science
Medicine 2026-03-18

Retired athletes' 'leaky' brain barriers persist years after final impact

Dublin researchers link ongoing blood-brain barrier breakdown to cognitive decline and toxic protein buildup in former collision sport athletes, pointing toward an MRI-based early warning system

How long does a head impact keep damaging the brain after the hit itself is over? For some retired professional athletes, the answer appears to be: years, possibly decades. The damage does not stop when the game ends.

A study published in Science Translational Medicine by researchers at Trinity College Dublin and the FutureNeuro Research Ireland Centre has identified a specific biological mechanism behind this persistent and ongoing damage. The blood-brain barrier (BBB) - a tightly sealed layer of specialized endothelial cells that controls what enters the brain from the bloodstream - remains structurally compromised in some retired collision and combat sport athletes long after they have stopped playing their sports and sustaining head impacts. This ongoing "leak" allows inflammatory proteins that should be excluded from brain tissue to seep across the compromised barrier, triggering a molecular cascade that includes the accumulation of p-Tau, a toxic misfolded protein closely associated with Alzheimer's disease, chronic traumatic encephalopathy, and other forms of progressive dementia.

The barrier that refuses to seal itself

The blood-brain barrier functions as the brain's most critical security checkpoint. Under normal conditions, it admits essential nutrients that the brain requires for function - glucose for energy, amino acids for neurotransmitter synthesis, oxygen for cellular respiration - while strictly blocking toxins, pathogens, large proteins, and inflammatory immune cells that could damage the delicate neural tissue on the other side. When working properly, the BBB is one of the most selective biological barriers in the human body, far more restrictive than the barriers protecting most other organs.

When this barrier fails, the brain loses its primary defense against blood-borne substances capable of triggering inflammation, damaging neurons, and initiating pathological protein aggregation cascades. Previous research had established that acute traumatic brain injuries - single severe concussions or skull fractures - can temporarily disrupt the BBB in the immediate aftermath of the event. What this Dublin study demonstrates for the first time is something more troubling: in some athletes with histories of repetitive head injuries (RHIs) accumulated over years of competitive sport, the disruption is not temporary at all. The barrier does not fully repair itself after the impacts stop. It remains leaky.

The research team, led by Professor Matthew Campbell (Professor of Neurovascular Genetics and Head of Trinity's Genetics Department) and Professor Colin Doherty (Professor of Epileptology and Head of Trinity's School of Medicine), used advanced dynamic contrast-enhanced MRI scans to visualize BBB integrity in retired professional rugby players and boxers. Compared to age-matched control subjects who had no history of contact sports participation, the retired athletes showed significant and widespread BBB breakdown across multiple brain regions.

The critical word in those findings is "retired." These were not active professional athletes sustaining ongoing impacts on a weekly basis. They had been away from their competitive sports for years. Yet their brain barriers remained measurably and significantly more permeable than those of their peers who had never participated in contact sports.

From barrier leakage to cognitive deterioration

The researchers cross-referenced their neuroimaging findings with standardized cognitive testing data collected from the same retired athletes. The correlation was direct and statistically robust: athletes with the most extensive barrier leakage visible on MRI scored significantly lower on neuropsychological tests measuring memory recall and executive function - the cognitive domains most commonly and most early affected in neurodegenerative diseases including Alzheimer's and CTE.

To understand the molecular mechanism linking BBB breakdown to cognitive decline, the team turned to post-mortem brain tissue from athletes who had been diagnosed with chronic traumatic encephalopathy (CTE) after death - the neurodegenerative condition most closely associated with repetitive head trauma and most commonly discussed in the context of American football. In these post-mortem tissue samples, the researchers found direct evidence that inflammatory proteins crossing the compromised barrier trigger a molecular cascade ending in pathological p-Tau formation and accumulation.

The proposed mechanistic sequence connects these findings into a coherent pathological narrative: repeated head impacts during an athletic career cause structural damage to the blood-brain barrier. The barrier fails to fully repair itself even after the athlete retires and the impacts cease. Inflammatory proteins from the bloodstream leak continuously through the persistent structural gaps into brain tissue that should be protected. These inflammatory proteins trigger cellular stress responses in neurons and surrounding glial cells that promote the misfolding and accumulation of tau protein into its pathological phosphorylated form. Over months and years, this progressive p-Tau accumulation produces the cognitive decline, mood disturbances, and neurological damage observed in affected former athletes.

Toward an MRI-based early warning system

One of the study's most immediately practical implications is diagnostic. Currently, CTE can only be definitively diagnosed through post-mortem examination of brain tissue - a limitation that means the condition is only confirmed after the affected individual has already died. There is no validated method for identifying which living retired athletes are developing the condition, which active athletes are accumulating damage that will manifest years later, or which individuals are at highest risk for progression to clinical dementia.

BBB-focused dynamic contrast-enhanced MRI scans could potentially fill this diagnostic gap. If the degree of barrier leakage reliably predicts the trajectory of future cognitive decline - a hypothesis supported by the correlation data in this study but not yet proven through prospective longitudinal follow-up - then imaging could serve as an early warning system. Retired athletes showing significant BBB disruption on MRI could be identified, enrolled in monitoring programs, and potentially offered early intervention before irreversible cognitive damage accumulates to symptomatic levels.

Dr. Chris Greene, first author of the study and FutureNeuro StAR Lecturer at RCSI University of Medicine and Health Sciences, pointed to an even more consequential possibility: MRI-based BBB assessment could potentially identify at-risk athletes while they are still actively playing, before retirement. This would have direct and immediate implications for return-to-play decisions following head injuries, for career-ending medical advice in athletes showing significant early barrier damage, and for the broader safety protocols governing collision sports.

Sealing the leak as a therapeutic strategy

If ongoing BBB breakdown is the primary driver sustaining the chronic disease process rather than merely a passive consequence of earlier damage, then repairing or preventing the breakdown becomes a legitimate and high-priority therapeutic target. The researchers suggest that future early-phase clinical trials could investigate whether existing pharmaceutical compounds or newly developed agents can seal the compromised barrier in affected individuals, potentially slowing or even halting the progression of neurodegenerative damage in at-risk former athletes.

This represents a conceptual shift in the field of sports-related brain injury research. Most research and clinical attention has focused on the acute phase - preventing concussions through rule changes and protective equipment, managing acute symptoms through rest protocols, and enforcing graduated return-to-play guidelines after concussion events. The Dublin findings suggest that even after all impacts have ceased entirely, the ongoing barrier failure continues independently to drive progressive brain damage through a self-sustaining inflammatory cycle. Treating the barrier itself, rather than solely preventing further traumatic impacts, opens a fundamentally new category of therapeutic intervention.

The populations not yet studied

The study examined retired professional rugby players and boxers - athletes at the extreme end of head impact exposure who sustained high volumes of repetitive contact over long and intensive competitive careers. These findings raise urgent and currently unanswered questions about much broader populations. Do amateur athletes, who typically sustain fewer and less severe impacts but who vastly outnumber professionals, show similar patterns of BBB disruption? What about athletes in women's collision sports, who have been chronically underrepresented in head injury research despite participating in the same contact activities? Does the severity of barrier damage scale proportionally with the cumulative number of impacts, the peak force of individual impacts, the age at which impacts began, or some combination of all these factors?

The research team has announced its intention to expand the investigation to include these broader populations. The answers will determine whether the observed BBB breakdown pattern is specific to professional-level impact exposure over many years or represents a more general and widespread biological vulnerability that extends to amateur participation and youth sports.

What the data cannot yet establish

Several important limitations apply to the current study despite its significant findings. The cohort of retired athletes examined was relatively small compared to the millions of individuals worldwide who participate in collision and combat sports at various competitive levels. Whether the observed BBB breakdown leads inevitably to clinical dementia in all affected individuals - or whether some people show measurable barrier leakage without ever progressing to symptomatic cognitive decline - has not been established. Protective factors that might distinguish affected from unaffected individuals remain poorly understood.

The causal chain proposed by the researchers, while biologically plausible and supported by both imaging and post-mortem molecular evidence, remains correlational in living subjects. The MRI findings demonstrate that barrier leakage and cognitive decline coexist in the same individuals, and the post-mortem tissue analysis provides a molecular mechanism connecting them. But a prospective longitudinal study following active athletes through their competitive careers and into retirement would be needed to definitively establish that BBB breakdown precedes and causally drives cognitive deterioration rather than occurring in parallel with it.

The post-mortem CTE tissue came from athletes already diagnosed with the disease - a diagnostically selected group that does not represent the full spectrum of retired contact sport athletes, many of whom live complete and cognitively healthy lives without developing significant neurological impairment. The factors distinguishing those who develop progressive disease from those who do not represent one of the most important unanswered questions in the field.

Professor Doherty framed the study's implications in public health and policy terms. The evidence now available, he argued, calls for proactive governmental involvement in addressing sports-related head trauma as a public health issue - particularly for amateur athletes and participants under 18, where the duty of care falls on teachers and volunteer parent-coaches rather than professional medical staff with expertise in concussion management.

Source: Trinity College Dublin and FutureNeuro Research Ireland Centre. Published in Science Translational Medicine. Led by Prof. Matthew Campbell and Prof. Colin Doherty, Trinity College Dublin. First author: Dr. Chris Greene, RCSI University of Medicine and Health Sciences. Contact: Thomas Deane, deaneth@tcd.ie, 867870784.